212
Participants
Start Date
June 29, 2018
Primary Completion Date
January 4, 2020
Study Completion Date
January 4, 2020
Theranova 400 Dialyzer
Dialysis performed in HD mode. Treatment duration for each individual subject will vary based on clinical requirements determined by the Investigator, based on the subject's need, residual renal function, access function, tolerance to HD/HDF and other relevant factors. The participating subjects' HD/HDF prescriptions should be kept stable throughout the study.
FX800 Dialyzer
Dialysis performed in HDF mode. Treatment duration for each individual subject will vary based on clinical requirements determined by the Investigator, based on the subject's need, residual renal function, access function, tolerance to HD/HDF and other relevant factors. The participating subjects' HD/HDF prescriptions should be kept stable throughout the study.
Investigational Site, Beijing
Investigational Site, Shanghai
Investigational Site, Hefei
Investigational Site, Hangzhou
Investigational Site, Wuhan
Investigational Site, Zhengzhou
Investigational Site, Guangzhou
Investigational Site, Chengdu
Baxter Healthcare Corporation
INDUSTRY
Vantive Health LLC
INDUSTRY